http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0008498-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47e6d64f3ca7f88ca5541672f0e21dca |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
filingDate | 2000-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7e7d0a2a557b90c5dd5017c7d53e9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499a2bddf3538c3f8f82afb51c6e0e0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45472f0d3cb8b21ebec77cecfb4b2910 |
publicationDate | 2002-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-0008498-A |
titleOfInvention | Method of promoting hydration of mucous membranes with certain uridine, adenine and cytidine diphosphates and their analogs |
abstract | "METHOD OF PROMOTING MUCOUS HYDRATION WITH CERTAIN DIFPHOSPHATES OF URIDINE, ADENIN AND CYTIDINE AND THEIR ANALOGUE". It is a method and preparation for stimulating hydration of mucous membranes in an individual in need of such treatment. The method comprises administering to the individual's mucous membranes a purinergic agonist receptor such as uridine 5'-diphosphate (UDP), dinucleotides, cytidine 5'-diphosphate (CDP), adenosine 5'-diphosphate (ADP), or their analogs and therapeutically useful derivatives, in an amount effective to stimulate mucin secretion. Pharmaceutical formulations and methods of manufacturing them are also presented. Methods of administering them could include: topical administration via a liquid, gel, cream, or as part of a contact lens or selective release membrane; or systemic administration via drops or nasal spray, inhalation by nebulizer or other device, oral form (liquid or pills), injectable, intraoperative instillation or suppository form. A method to facilitate sputum sputum for the purpose of detecting cellular abnormalities indicative of lung disease is also presented. |
priorityDate | 1999-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.